Role of phosphoinositide 3OH-kinase in autocrine transformation by PDGF-BB

T Rosenmüller1, K Rydh, E Nånberg

  • 1Department of Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Sweden.

Insights

Phosphoinositide 3OH-kinases (PI3K) are crucial for cell transformation, driving altered morphology and migration. Inhibiting PI3K with LY294002 reversed these transformed characteristics in murine fibroblasts.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Phosphoinositide 3OH-kinases (PI3K) are lipid kinases regulating key cellular processes like migration, cytoskeletal rearrangements, and survival.
  • These processes are critical hallmarks of cellular transformation and cancer development.

Purpose of the Study:

  • To investigate the functional role of PI3K in the development of transformed morphology and migratory responses in murine fibroblasts.
  • To elucidate the downstream signaling pathways involved in PI3K-mediated transformation.

Main Methods:

  • Utilized specific PI3K inhibitor LY294002 on NIH/sis and COL1A1/NIH3T3 murine fibroblast cell lines.
  • Stimulated cells via autocrine expression of platelet-derived growth factor-BB (PDGF-BB).
  • Assessed morphological changes, density-independent growth, focus formation, and random cell migration.

Main Results:

  • Prolonged treatment with LY294002 reversed transformed morphology, inhibited density-independent growth, and prevented focus formation.
  • Functional PI3K activity was essential for the development of transformed morphology in both cell lines.
  • LY294002 treatment completely disrupted random cell migration.
  • Activation of the small GTPase Rac was identified as a prerequisite for the transformation signal downstream of PI3K.
  • Evidence of a suramin-insensitive PI3K activity was observed, potentially linked to intracellular PDGF receptor pools.

Conclusions:

  • Intact PI3K activity is indispensable for the morphological alterations characteristic of PDGF-induced autocrine transformation.
  • PI3K signaling is a critical regulator of cell migration and survival in the context of cellular transformation.
  • Targeting PI3K may represent a therapeutic strategy to revert or inhibit cancer cell phenotypes.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...